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Protective role of ALDH2 against 
acetaldehyde-derived DNA 
damage in oesophageal squamous 
epithelium
Yusuke Amanuma1,2, Shinya Ohashi2, Yoshiro Itatani3, Mihoko Tsurumaki2, 
Shun Matsuda4, Osamu Kikuchi1, Yukie Nakai2, Shin’ichi Miyamoto1, Tsunehiro Oyama5, 
Toshihiro Kawamoto5, Kelly A. Whelan6, Hiroshi Nakagawa6, Tsutomu Chiba1, 
Tomonari Matsuda4 & Manabu Muto2
Acetaldehyde is an ethanol-derived definite carcinogen that causes oesophageal squamous 
cell carcinoma (ESCC). Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme that eliminates 
acetaldehyde, and impairment of ALDH2 increases the risk of ESCC. ALDH2 is produced in various 
tissues including the liver, heart, and kidney, but the generation and functional roles of ALDH2 in the 
oesophagus remain elusive. Here, we report that ethanol drinking increased ALDH2 production in 
the oesophagus of wild-type mice. Notably, levels of acetaldehyde-derived DNA damage represented 
by N2-ethylidene-2′-deoxyguanosine were higher in the oesophagus of Aldh2-knockout mice than in 
wild-type mice upon ethanol consumption. In vitro experiments revealed that acetaldehyde induced 
ALDH2 production in both mouse and human oesophageal keratinocytes. Furthermore, the N2-
ethylidene-2′-deoxyguanosine levels increased in both Aldh2-knockout mouse keratinocytes and 
ALDH2-knockdown human keratinocytes treated with acetaldehyde. Conversely, forced production 
of ALDH2 sharply diminished the N2-ethylidene-2′-deoxyguanosine levels. Our findings provide new 
insight into the preventive role of oesophageal ALDH2 against acetaldehyde-derived DNA damage.
Oesophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of 
cancer-related death1. The overall 5-year survival of patients with oesophageal cancer is poor, at 15–25%2. 
Squamous cell carcinoma is the most frequent histologic type of oesophageal cancer, particularly in East 
Asian countries2. Chronic alcohol consumption and gene variants encoding enzymes involved in alcohol 
metabolism are closely associated with the risk of oesophageal squamous cell carcinoma (ESCC)3.
Alcoholic beverages contain varying ethanol concentrations. Ingested ethanol is absorbed mainly 
from the duodenum and jejunum, and then metabolized to acetaldehyde by alcohol dehydrogenase 
in the liver4. Acetaldehyde is a highly reactive compound that causes DNA damage5,6. It reacts with 
deoxyguanosine, a substrate of DNA, and forms DNA adducts such as N2-ethylidene-2′ -deoxyguanosine 
(N2-ethylidene-dG), N2-ethyl-2′ -deoxyguanosine (N2-Et-dG) and 1,N2-propano-2′ -deoxyguanosine7, 
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which are involved in mutagenesis8,9. Among them, N2-ethylidene-dG is the most sensitive marker for 
acetaldehyde exposure10,11, and is commonly analysed to detect acetaldehyde-derived DNA damage11–13.
Aldehyde dehydrogenase 2 (ALDH2) is a mitochondrial enzyme that detoxifies acetaldehyde to 
acetic acid14. Approximately 35–45% of East Asian individuals have a single nucleotide polymorphism 
(G1510A) in the ALDH2 gene15,16, which results in a Glu504Lys replacement with reduced ability to oxi-
dize acetaldehyde. Therefore, their blood, salivary, and expiratory acetaldehyde levels after alcohol drink-
ing are highly elevated compared with wild-type ALDH2 homozygotes17–19. Accordingly, heavy alcohol 
consumers with this mutant ALDH2 allele are at risk of ESCC because of the potential exposure of their 
oesophageal tissues to high amounts of acetaldehyde20–23.
Based on extensive epidemiological data, acetaldehyde associated with consumption of alcoholic bev-
erages is defined as a ‘group 1 carcinogen’ for the oesophagus by the International Agency for Research 
on Cancer24. However, little is known about how oesophageal epithelial cells are affected by acetaldehyde. 
In fact, ALDH2 is produced in various tissues, including the liver, heart, and kidney25, but its production 
and functional roles in oesophageal epithelium remain elusive. In this study, we addressed the produc-
tion and role of ALDH2 in oesophageal epithelium. We found that ALDH2 production was increased by 
acetaldehyde in oesophageal squamous epithelium and suppressed acetaldehyde-derived DNA damage.
Results
Effects of ethanol drinking on ALDH2 production and DNA damage in the oesophagus of 
Aldh2+/+ and Aldh2–/– mice. To examine whether ALDH2 was induced in the oesophagus by alcohol 
drinking and how it influenced alcohol-induced acetaldehyde-derived DNA damage in vivo, Aldh2 wild-
type (Aldh2+/+) and Aldh2-knockout (Aldh2–/–) mice were given 10% ethanol to drink for 8 weeks. Neither 
strain showed obvious histological changes in the oesophagus following ethanol drinking (Fig. 1a, upper 
panels). Of note, ALDH2 levels increased in the basal and parabasal cells of the oesophageal epithelium 
in 6 out of 10 Aldh2+/+ mice subjected to ethanol drinking, whereas they did not increase in Aldh2+/+ 
mice without ethanol drinking. Aldh2–/– mice did not exhibit ALDH2 production in the presence or 
absence of ethanol drinking (0 of 10 mice) (Fig. 1a, middle panels; Table 1).
Next, we examined the levels of phosphorylated histone H2AX (γ -H2AX), a well-established marker 
of DNA damage26, and N2-ethylidene-dG in the oesophagus. γ -H2AX indexes as well as N2-ethylidene-dG 
levels in Aldh2+/+ mice with ethanol drinking were significantly higher than those without ethanol drink-
ing (p < 0.001; Fig. 1b), (p = 0.02; Fig. 1c), respectively. Moreover, both levels were significantly elevated 
in Aldh2–/– mice with ethanol drinking compared to Aldh2+/+ mice with ethanol drinking (p = 0.02; 
Fig.  1b), (p = 0.03; Fig.  1c), respectively, although there was no significant difference between Aldh2–/– 
and Aldh2+/+ mice without ethanol drinking (Fig. 1b,c). Thus, ethanol drinking induced the production 
of ALDH2 in the oesophagus, and acetaldehyde-derived oesophageal DNA damage was enhanced in the 
absence of Aldh2 gene expression.
Effects of acetaldehyde on DNA damage and ALDH2 production in human oesophageal kerat-
inocytes. To examine how acetaldehyde affects oesophageal keratinocytes, we treated human oesoph-
ageal keratinocytes immortalized with human telomerase reverse transcriptase (hTERT; EPC2-hTERT 
cells) with acetaldehyde and assessed DNA damage and cell viability. As shown in Fig. 2a, acetaldehyde 
induced DNA adduct formation in a dose-dependent manner at doses of less than or equal 1 mM that 
did not induce substantive cell death (Fig. 2b).
Next, we hypothesized that ALDH2 levels would be increased in oesophageal keratinocytes by acetal-
dehyde administration, as an autonomous cytoprotective mechanism. To test this hypothesis, we treated 
three independent human oesophageal keratinocyte cell lines (EPC2-hTERT, EPC1-hTERT, and HEEC) 
carrying wild-type ALDH2 with acetaldehyde. We found that each of these cell lines displayed enhanced 
expression of ALDH2 mRNA and protein levels upon stimulation with acetaldehyde in times and 
dose-dependent manners (Fig.  2c,d). These data indicate that acetaldehyde directly increased ALDH2 
production in oesophageal epithelial cells.
Effects of depletion of ALDH2 on acetaldehyde-induced DNA damage. To determine the 
functional role of ALDH2 in human oesophageal keratinocytes, we knocked down ALDH2 expression 
by small interfering RNA (siRNA) in EPC2-hTERT cells. ALDH2-knockdown by siRNA (siALDH2-A 
and siALDH2-B) reduced ALDH2 protein production, whereas a nonsilencing siRNA sequence did not 
(Fig.  3a). The basal N2-ethylidene-dG level was significantly higher in both ALDH2-knockdown cells 
than in the control cells (p < 0.001 and p < 0.001, respectively) (Fig.  3b). Furthermore, acetaldehyde 
treatment markedly increased the N2-ethylidene-dG level in both ALDH2-knockdown cells compared 
with control cells (p = 0.007 and p = 0.016, respectively) (Fig. 3b).
To confirm the enhancement of acetaldehyde-derived DNA damage by ALDH2 impairment, we 
also conducted ex vivo experiments using mouse oesophageal keratinocytes isolated from Aldh2+/+ and 
Aldh2–/– mice and treated with acetaldehyde. ALDH2 production was absent in Aldh2–/– oesophageal 
keratinocytes irrespective of acetaldehyde treatment, whereas it was increased by this treatment in kerat-
inocytes of Aldh2+/+ mice (Fig. 3c). Consistent with the results of the siRNA experiments (Fig. 3b), the 
basal N2-ethylidene-dG level was significantly higher in Aldh2–/– cells than in Aldh2+/+ cells (p < 0.001) 
(Fig. 3d). Moreover, after acetaldehyde treatment, the N2-ethylidene-dG level was significantly elevated 
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in Aldh2–/– cells, whereas it was not increased in Aldh2+/+ cells (p < 0.001) (Fig. 3d). These results col-
lectively suggest that endogenous ALDH2 plays a role in preventing acetaldehyde-derived DNA damage 
in oesophageal keratinocytes.
Effects of ALDH2 overexpression on acetaldehyde-derived DNA damage. Finally, we exam-
ined whether ALDH2 overexpression would decrease acetaldehyde-derived DNA damage. The control 
EPC2-hTERT cells, transduced with a lentiviral control vector bearing a FLAG-tag but lacking the ALDH2 
coding site, showed production of endogenous ALDH2 protein (52.6 kDa). EPC2-hTERT cells stably over-
expressing wild-type ALDH2 or mutant ALDH2, designated as EPC2-ALDH2 or EPC2-ALDH2MT cells 
respectively, showed substantial production of both exogenous FLAG-tagged ALDH2 protein (53.6 kDa) 
and endogenous ALDH2 protein (52.6 kDa) (Fig.  4a). Basal N2-ethylidene-dG levels were significantly 
Figure 1. Effects of ethanol drinking in Aldh2+/+ and Aldh2–/– mice oesophagus. The mice were allowed 
to drink 10% ethanol or water alone (controls) for 8 weeks. Data are presented as the mean ± SD. (a) 
Hematoxylin and eosin (H&E) and immunohistochemical staining for ALDH2 (arrowheads) and γ -H2AX 
(arrows). Scale bar = 50 μ m. (b) The index of γ -H2AX staining is defined as the proportion of cells staining 
positive for γ -H2AX in the oesophageal basal cell layer (**p < 0.01, *p < 0.05 between the indicated groups; 
n = 5 in each group; n.s., not significant). (c) N2-ethylidene-dG level in the oesophagus of Aldh2+/+ and 
Aldh2–/– mice with or without ethanol consumption (*p < 0.05 between the indicated groups; n = 5 in each 
group).
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lower in EPC2-ALDH2 cells than in either control cells (p = 0.032) or EPC2-ALDH2MT cells (p = 0.02) 
(Fig.  4b). Most importantly, the N2-ethylidene-dG production induced by acetaldehyde treatment was 
also significantly smaller in EPC2-ALDH2 cells than in control (p < 0.001) or EPC2-ALDH2MT cells 
(p = 0.001) (Fig. 4b).
Discussion
Here, we found that ethanol drinking increased ALDH2 production in the oesophagus of Aldh2+/+ mice. 
Compared with Aldh2+/+ mice, the Aldh2–/– mice displayed greatly enhanced acetaldehyde-derived DNA 
damage in their oesophagus. We also found that acetaldehyde directly enhanced ALDH2 production in 
both mouse and human oesophageal keratinocytes in vitro, and that acetaldehyde-derived DNA damage 
was augmented in both human ALDH2-knockdown keratinocytes and Aldh2–/– mouse keratinocytes. 
Furthermore, overexpression of wild-type ALDH2, but not mutant ALDH2, reduced acetaldehyde-derived 
DNA damage in human keratinocytes. These data indicate that oesophageal ALDH2 plays a protective 
role in reducing acetaldehyde-derived DNA damage in keratinocytes.
Our in vivo study revealed that ethanol drinking induced ALDH2 production in the basal and para-
basal layers of the mouse oesophagus. It is controversial whether ALDH2 protein is produced in the 
oesophagus. Yin et al. reported that agarose isoelectric focusing did not show ALDH2 expression in 
human oesophageal mucosa27. By contrast, in an immunohistochemistry study, Morita et al. found that 
ALDH2 was produced in the oesophageal epithelium and that the expression levels were closely associ-
ated with the patients’ drinking habits28. Our data are in agreement with those reported by Morita et al. 
Moreover, we demonstrated that oesophageal ALDH2 production was induced by acetaldehyde exposure 
in human and mouse oesophageal keratinocytes. These results suggest that the increased oesophageal 
ALDH2 levels induced by ethanol drinking are triggered by the direct exposure of oesophageal mucosal 
cells to acetaldehyde rather than to ethanol per se.
To determine the role of oesophageal ALDH2 in acetaldehyde-derived DNA damage, we conducted 
in vitro and ex vivo experiments in which the same amount of acetaldehyde was administered to both 
human and mouse oesophageal keratinocytes with genetic modifications to ALDH2 production levels, 
and found a strong negative association between the extent of acetaldehyde-derived DNA damage and 
ALDH2 levels. These results indicate that oesophageal ALDH2 might act genoprotectively for acetalde-
hyde as an autonomous defence response to acetaldehyde exposure. Thus, DNA damage might be caused 
by acetaldehyde exposure that exceeds the innate defence capacity of oesophageal keratinocytes.
Immunohistochemical analysis of γ -H2AX in our in vivo study showed that DNA damage was accu-
mulated at the basal layer of the oesophageal epithelium in Aldh2–/– mice following ethanol drinking. 
Acetaldehyde-derived DNA adducts are known to induce DNA–DNA crosslinking, which leads to gene 
mutations and double-strand DNA breaks, and ultimately to the induction of γ -H2AX expression6,29. 
This result indicates that the basal cells in the oesophageal epithelium might be susceptible to DNA 
damage induced by acetaldehyde.
In our in vivo study, obvious histologic abnormalities were not found in Aldh2–/– mice with eth-
anol drinking for 8 weeks, although DNA adducts levels highly increased in those mice. Similarly, 
N2-ethylidene-dG levels increased in acetaldehyde-treated ALDH2-knockdown cells; however, those cells 
were not transformed in the present study. Moreover, proliferative and migrative activities of those cells 
were not influenced by acetaldehyde treatment (supplementary Figure S1). Accordingly, it is still unclear 
whether DNA adducts are the direct initiators of alcohol-related carcinogenesis in the oesophagus.
In our study, overexpression of wild-type ALDH2 in the oesophageal mucosal cells reduced 
acetaldehyde-derived DNA damage. Recently, ALDH2 is reported as an important mediator of endog-
enous cytoprotection in the heart when it is subjected to ischemia30,31. In addition, overexpression of 





 Water 10 0
 Ethanol 4 6
Aldh2–/– mice
 Water 10 0
 Ethanol 10 0
Table 1.  ALDH2 protein production in the oesophagus of Aldh2+/+ and Aldh2–/– mice treated with or 
without ethanol drinking. We defined positive of ALDH2 protein levels when more than 50% of the cells 
were stained with anti-ALDH2 antibody in the basal and parabasal layers of the oesophageal epithelium. 
Ethanol drinking induced ALDH2 in the oesophageal epithelium in 6 out of 10 Aldh2+/+ mice, whereas 
there was no induction in the water group of Aldh2+/+ mice ( p = 0.011 by Fisher’s exact test).
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Figure 2. Effects of acetaldehyde treatment on human oesophageal keratinocytes. Data are presented 
as the mean ± SD. (a) N2-ethylidene-dG levels in DNA isolated from EPC2-hTERT cells treated with the 
indicated concentrations of acetaldehyde for 72 h (**p < 0.01, *p < 0.05 vs. the cells treated with  
0 mM acetaldehyde; n = 3). (b) Cell viability of EPC2-hTERT cells treated with various concentrations 
of acetaldehyde for 72 h. The ratio of viable cells is expressed relative to the cells treated with 0 mM 
acetaldehyde (n = 6 for each acetaldehyde concentration). (c) ALDH2 mRNA expression levels in EPC2-
hTERT, EPC1-hTERT, and HEEC cells after treatment with acetaldehyde (1 mM) for 72 h. The mRNA levels 
for the ALDH2 gene relative to the cells treated with 0 mM acetaldehyde were determined by quantitative 
real-time reverse transcription PCR; the gene for β -actin served as an internal control (**p < 0.01 vs. the 
cells treated with 0 mM acetaldehyde; n = 3). (d) ALDH2 protein production levels in EPC2-hTERT, 
EPC1-hTERT, and HEEC cells after treatment with the indicated concentrations of acetaldehyde for 72 h 
(upper panels) or with acetaldehyde (0.2 mM) for the indicated time points (lower panels). ALDH2 protein 
production levels were determined by western blotting, and β -actin served as a loading control.
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cell injury in human cardiac myocytes or umbilical vein endothelial cells33,34. These findings sup-
port the notion that ALDH2 induction or activation might have a preventive potential to alcohol- or 
acetaldehyde-induced cytotoxicity in the oesophagus.
A limitation of this study is that we could not demonstrate ALDH2 enzymatic activity in oesopha-
geal tissues and keratinocytes. To show such activity, we conducted experiments to quantify the reduc-
tion of nicotinamide adenine dinucleotide production by ALDH2 as described previously35. We could 
measure the ALDH activity in mouse liver (0.9 ± 0.22 nmol/min/mg protein); however, its activity in 
the mouse oesophagus and human oesophageal keratinocytes were undetectable. Because the ALDH2 
expression level determined by western blotting was very low in the mouse oesophagus compared with 
the liver (Supplement Figure S2), the above experiments might not be able to determine ALDH activity 
in the mouse oesophagus. Additional research is warranted to elucidate the relationship between ALDH2 
expression level and its activity.
In conclusion, we have demonstrated here that ALDH2 production in oesophageal keratinocytes is 
induced by acetaldehyde and that oesophageal ALDH2 acts cytoprotectively as a local defence mecha-
nism against acetaldehyde-derived DNA damage.
Figure 3. Facilitation of acetaldehyde-derived DNA damage caused by ALDH2 depletion in human 
and mouse oesophageal keratinocytes. EPC2-hTERT cells were treated with 0 or 0.2 mM acetaldehyde 
for 72 h following transfection with siRNA targeting ALDH2 mRNA translation (siALDH2). Oesophageal 
keratinocytes isolated from Aldh2+/+ or Aldh2–/– mice were treated with 0 or 0.2 mM acetaldehyde for 
72 h. Data are presented as the mean ± SD. (a) Western blotting showing the effect of RNA interference 
for ALDH2 on EPC2-hTERT cells; β -actin served as a loading control for whole cell lysates. (b) N2-
ethylidene-dG levels in EPC2-hTERT cells treated with or without siALDH2-A or siALDH2-B in 0 or 
0.2 mM acetaldehyde (**p < 0.01, *p < 0.05 between pairs of indicated groups; n = 3 in each group). (c) 
Western blotting showing ALDH2 levels in mouse oesophageal keratinocytes in 0 or 0.2 mM acetaldehyde; 
β -actin served as a loading control. (d) N2-ethylidene-dG level in oesophageal keratinocytes isolated from 
Aldh2+/+ and Aldh2–/– mice in 0 or 0.2 mM acetaldehyde (**p < 0.01 between pairs of indicated groups; n = 5 
in each group).
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Methods
Mouse preparation and alcohol drinking. Six-week-old male Aldh2–/– mice36, backcrossed with 
C57BL/6 mice, were obtained from the Department of Environmental Health, University of Occupational 
and Environmental Health (Kitakyushu, Japan). Age-matched control C57BL/6 male mice, which carry 
the wild-type Aldh2, were purchased from Charles River Laboratories Japan Inc. (Yokohama, Japan). 
All experiments conformed to the relevant regulatory standards and were approved by the Institutional 
Animal Care and Use Committee of Kyoto University (Med Kyo 14522). The genotype of Aldh2 was 
determined by polymerase chain reaction (PCR) amplification as described36. Aldh2+/+ and Aldh2–/– 
mice were allowed to drink water with or without 10% ethanol supplementation freely for 8 weeks as 
described37. Mice were euthanized painlessly under anesthesia with diethyl ether inhalation followed 
by cervical dislocation. Oesophageal tissues were collected in 4% Paraformaldehyde Phosphate Buffer 
Solution (Wako Pure Chemical Industries, Ltd., Osaka, Japan) for immunohistochemistry (n = 10 each 
group) or frozen in liquid nitrogen and stored at –80 °C for analysis of DNA adducts (n = 5 each group).
Oesophageal keratinocyte culture and treatments. Primary mouse oesophageal epithelial cells 
(keratinocytes) were isolated from C57BL/6 mice and grown as described38. Two independent non-
transformed human oesophageal keratinocyte cell lines, EPC1-hTERT and EPC2-hTERT, were obtained 
from the Cell Culture Core of the Center for Molecular Studies in Digestive and Liver Diseases at the 
University of Pennsylvania39,40. They were cultured in Keratinocyte Serum-Free Media (Life Technologies 
Corp., Carlsbad, CA, USA), supplemented with 40 μ g/mL of Bovine Pituitary Extract, 1 ng/mL Epidermal 
Growth Factor, and 1% penicillin/streptomycin. A primary human oesophageal epithelial cell line, 
HEEC41, was purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured in 
Epithelial Cell Medium-2 (EpiCM-2). The ALDH2 genotype of human oesophageal keratinocytes was 
assessed using SmartAmp ALDH2 Typing Kits (DNAFORM, Yokohama, Japan). Cells were treated with 
acetaldehyde (0–4 mM) (Sigma-Aldrich, St. Louis, MO, USA) for 0–72 h. Cell viability was determined 
by sulfonated tetrazolium salt WST-1 assays according to the manufacturer’s instructions (Roche Applied 
Science, Penzberg, Germany).
Figure 4. Reduction of acetaldehyde-derived DNA damage by overexpression of ALDH2 in EPC2-
hTERT cells. EPC2-hTERT cells were transduced with lentiviral pLEX-ALDH2 or pLEX-ALDH2MT vectors 
to establish EPC2-ALDH2 or EPC2-ALDH2MT cells, respectively, which stably overexpressed wild-type or 
mutant ALDH2. As control cells, we transduced EPC2-hTERT cells with a lentiviral control vector bearing 
a FLAG-tag without an ALDH2 coding site. Data are presented as the mean ± SD. (a) Western blotting 
showing overproduction of FLAG-tagged ALDH2 protein (53.6 kDa) and non-FLAG-tagged ALDH2 
(52.6 kDa) in EPC2-ALDH2 and EPC2-ALDH2MT cells using antibodies to FLAG M2 and ALDH2; β -actin 
served as a loading control. (b) N2-ethylidene-dG levels in EPC2-ALDH2, EPC2-ALDH2MT, and control cells 
treated with 0 or 0.2 mM acetaldehyde for 72 h (**p < 0.01, *p < 0.05 between the indicated groups; n = 3 in 
each group; n.s., not significant).
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Generation of the ALDH2 transgene construct. To establish a stably transfected cell line express-
ing ALDH2, we produced a lentiviral plasmid vector. The ALDH2 open reading frame was PCR-amplified 
using Mammalian Gene Collection Human ALDH2 Sequence-Verified cDNA (Clone ID: 5477768) 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) as a template with PrimeSTAR Max DNA Polymerase 
(Takara Bio Inc., Otsu, Japan) and ALDH2-Forward (5′ –AAAAAGAATTCATGTTGCGCGCTGCCGC
C–3′ ) and ALDH2-Reverse (5′ –AAAAACTCGAGTTATGAGTTCTTCTGAGG–3′ ) primers. The ampli-
fied ALDH2 fragment was ligated into the EcoRI and XhoI sites of a pCMV-Tag2B vector (Stratagene 
Corp., La Jolla, CA, USA) by Ligation Mix (Takara Bio Inc.), resulting in the creation of pCMV-ALDH2. 
pCMV-ALDH2 was cut by NheI and XhoI to include the coding site for FLAG-tagged ALDH2. The 
lentiviral plasmid pLEX-MCS vector42 (Thermo Fisher Scientific Inc.) was cut by SpeI and XhoI. The 
site of FLAG-ALDH2 was cloned into a pLEX-MCS vector. The construct sequence was confirmed by 
sequencing, and designated as the pLEX-ALDH2 plasmid vector. To produce recombinant lentiviruses, 
pMD2.G and psPAX2 (Addgene, Cambridge, MA, USA) were cotransfected with the pLEX-ALDH2 
vector into HEK293T cells using Lipofectamine LTX (Life Technologies Corp.). Finally, a recombinant 
ALDH2-coding lentivirus was transduced into EPC2-hTERT cells, and the cells were selected by puro-
mycin (1 μ g/ml) (Sigma-Aldrich). We constructed a control vector bearing a FLAG-tag and lacking the 
ALDH2 coding site. We also constructed a lentiviral plasmid vector including a mutant ALDH2 with 
a nucleotide substitution (G1510A; Glu504Lys) in exon 12 of the ALDH2 locus—this point mutation 
causes catalytic deficiency of human ALDH215—using the PrimeSTAR Mutagenesis Basal Kit (Takara Bio 
Inc.) according to the manufacturer’s protocol, and designated this as the pLEX-ALDH2MT vector. The 
mutated primers were as follows: forward (5′ –ATACACTAAAGTGAAAACTGTCACAG–3′ ) and reverse 
(5′ –TTTCACTTTAGTGTATGCCTGCAGCC–3′ ).
Immunohistochemistry. Immunohistochemistry was performed as described43. Primary antibodies 
and the titers used were as follows: rabbit polyclonal anti-ALDH2 (Ag7452; 15310-1-AP; Proteintech 
Group, Inc., Chicago, IL, USA; 1:500); rabbit monoclonal anti-phospho-histone H2AX (Ser139; 20E3; 
Cell Signaling Technology, Inc., Danvers, MA, USA; 1:480). Immunostained tissues were assessed using 
a Keyence BIOREVO BZ-9000 microscope (Keyence Corp., Osaka, Japan). For the staining of ALDH2, 
we defined the sample as positive when more than 50% of the cells were stained with anti-ALDH2 in the 
basal and parabasal layer of the oesophageal epithelium together. We present the ratio of cells positive for 
phosphorylated histone H2AX (γ -H2AX) to the total number of cells, determined using a Hybrid Cell 
Count BZ-H2C system (Keyence Corp.), as a staining index.
DNA isolation, digestion, and quantification of N2-ethylidene-dG. DNA was isolated from tis-
sue specimens or cell pellets as described11. To quantify acetaldehyde-derived DNA damage, we meas-
ured the N2-ethylidene-dG level in the oesophagus of mice and cultured cells as described37. Briefly, 
NaBH3CN (100 mM) (Sigma-Aldrich), a reducing reagent, was added to DNA samples. This converts 
N2-ethylidene-dG to stable N2-Et-dG. As the endogenous N2-Et-dG level in tissues is extremely low, 
the N2-Et-dG level that is converted from N2-ethylidene-dG indicates the endogenous N2-ethylidene-dG 
level10. The DNA adduct standard, N2-Et-dG, and its stable isotope, [U-15N5]-labeled N2-Et-dG, were syn-
thesized as described11. DNA samples were digested as described11, and subjected to liquid chromatogra-
phy tandem mass spectrometry (LC/MS/MS). LC/MS/MS analyses were performed using a Shimadzu LC 
system (Shimadzu Corp., Kyoto, Japan) interfaced with a Quattro Ultimo triple-stage quadrupole mass 
spectrometer or an ACQUITY UPLC H-Class system interfaced with a XEVO-TSQ triple-stage quadru-
pole mass spectrometer (Waters Corp., Milford, MA, USA) as reported11. Shim-pack XR-ODS columns 
(3.0 × 75 mm, 2.2 μ m; Shimadzu Corp.) or ACQUITY UPLC BEH C18 columns (2.1 × 100 mm, 1.7 μ m; 
Waters Corp.) were used to separate the samples.
TaqMan gene expression assays. RNA was isolated using RNeasy Plus Mini Kits (QIAGEN Inc., 
Hilden, Germany) and cDNA was synthesized using PrimeScript RT reagent kits (Takara Bio Inc.) accord-
ing to the manufacturer’s instructions. Real-time reverse-transcription PCR was done with TaqMan Gene 
Expression Assays (Life Technologies Corp.) for ALDH2 (Assay ID; Hs01007998_m1) and for β -actin 
(Assay ID; Hs99999903_m1) using a LightCycler 480 Instrument II (Hoffmann-La Roche Ltd, Basel, 
Switzerland) as described44. All PCR reactions were performed in triplicate. The relative mRNA expres-
sion level was normalized to that of β -actin as an internal control.
Western blot analysis. Whole cell lysates were prepared as described45. The denatured protein sam-
ples (20 μ g) were fractionated on Any kD Mini-PROTEAN TGX Precast Gels (Bio-Rad Laboratories, 
Inc., Hercules, CA, USA). Primary antibodies and the titers used for western blotting were as fol-
lows: goat polyclonal anti-ALDH2 (N-14) (sc-48838; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, 
USA; 1:1000); mouse monoclonal anti-FLAG M2 (F1805; Sigma-Aldrich; 1:1000); rabbit monoclonal 
anti-β -actin (13E5; Cell Signaling Technology, Inc.; 1:2000). These were then reacted with the appro-
priate horseradish peroxidase-conjugated secondary antibody (GE Healthcare, Little Chalfont, UK). The 
signal was visualized using an Immobilon Western Chemiluminescent Horseradish Peroxidase Substrate 
(Merck Millipore, Darmstadt, Germany) and was exposed using a ChemiDoc XRS system equipped with 
Image Lab software (Bio-Rad Laboratories, Inc.).
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RNA interference. To suppress endogenous ALDH2 induction, FlexiTube siRNA (QIAGEN Inc.) for 
ALDH2 (two independent sequences: ALDH2-A, SI03059973; ALDH2-B, SI03087070) were employed. 
AllStars Negative Control (1027280) (QIAGEN Inc.) was used as a nonsilencing control. The siRNAs (10 
nM) were transfected transiently using HiPerFect transfection reagent (QIAGEN Inc.), according to the 
manufacturer’s instructions.
Statistical analysis. Data are presented as the mean ± standard deviation. The data were first tested 
for normality of distribution. The differences between two groups were analysed using two-tailed paired 
Student’s t tests for equal variance data or using Welch’s t test for the unequal variance data presented in 
Figs 1b,c and 2a,c and 3d. Student’s t test followed by the Bonferroni post hoc test was used to analyse 
the data presented in Fig.  3b. One-way analysis of variance (ANOVA) followed by Tukey’s post hoc 
analysis was used to analyse the data shown in Fig.  4b. Fisher’s exact test was used to assess the rela-
tionship between ALDH2 expression and drinking ethanol in Aldh2+/+ mice (data presented in Table 1). 
Statistical analyses were performed using SPSS software (version 17; IBM Corp., Armonk, NY, USA). 
P-values < 0.05 were considered significant.
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